Fintel reports that on January 10, 2025, Stifel downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to Hold ...

Fintel reports that on January 10, 2025, Jefferies downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to ...

JPMorgan upgraded IGM Biosciences (IGMS) to Neutral from Underweight without a price target The firm says that with the company announcing ...

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell ...

Stifel downgraded IGM Biosciences (IGMS) to Hold from Buy with a price target of $2.50, down from $27. Th firm cites the company’s “surprising ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Joshua Rodriguez is a writer with a passion for helping people understand the impact of their financial decisions (good or bad). His articles on mortgages, home equity loans, credit cards ...

iShares Trust - iShares Expanded Tech Sector ETF is an exchange traded fund launched by BlackRock, Inc. The fund is managed by BlackRock Fund Advisors. It invests in public equity markets of the ...

I have been in the financial advising business for 23 years. Along the way, I've worked with and in competition against various advisors of all forms from banks, brokerages, wholesalers ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever IGM Financial Inc operates as a wealth and asset management company in Canada.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...